Nat Chem BiolJClub
Drug-controlled CAR T cells through the regulation of cell-cell interactions.
Nature Chemical Biology · · Journal Article · Open access
Scheller, Giordano Attianese + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Venetoclax-controlled DROP-CAR T cells enable dose-dependent regulation of tumor targeting, reducing T cell binding to tumor cells in vitro and in vivo.
- Why it matters: Controlling CAR T cell activity is crucial to minimize toxicities and exhaustion caused by chronic antigen exposure, yet current designs lack effective, nonimmunogenic, drug-responsive switches.
- What they did: Researchers designed and optimized a human-origin protein-protein interaction to create venetoclax-controlled DROP-CARs, demonstrating their function and potential for dual regulation and logic gating in cell signaling.
- The result: The findings suggest that DROP-CAR T cells can be precisely regulated with small molecules, offering a promising approach for safer, more effective clinical CAR T cell therapies.
The findingWhy it mattersWhat they didThe result
- Open access
- 2 cites